Literature DB >> 8496525

Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon.

Y Okazaki1, K Kodama, H Sato, M Kitakaze, A Hirayama, M Mishima, M Hori, M Inoue.   

Abstract

OBJECTIVES: The aim of this study was to test the hypothesis that the warm-up phenomenon is attributable to a reduction of increased myocardial oxygen consumption rather than to increased coronary blood flow during exercise.
BACKGROUND: The underlying mechanism of the warm-up phenomenon is not elucidated.
METHODS: Thirteen patients with effort angina were subjected to two consecutive supine ergometer exercise tests performed 15 min apart. All patients had severe proximal stenosis (> 90%) in the left anterior descending coronary artery. Great cardiac vein flow was measured before and during exercise. Both regional myocardial oxygen consumption and adenosine release were determined.
RESULTS: Exercise was continued for significantly longer before angina onset in the second than in the first exercise test (507 +/- 44 vs. 410 +/- 42 s, p < 0.01). The extent of ST segment depression in lead V5 of the electrocardiogram (ECG) was larger at the time of angina onset in the first (1.7 +/- 0.2 mm) than in the second (1.1 +/- 0.2 mm, p < 0.01) exercise test. Neither systemic hemodynamic variables nor great cardiac vein flow differed between the first and second exercise tests. In contrast, regional myocardial oxygen consumption assessed at 3 min of exercise was significantly (p < 0.01) less in the second than in the first test (8.0 +/- 0.8 vs. 8.7 +/- 0.9 ml/min). Adenosine release during the second test was higher (p < 0.05) than in the first test (2.5 +/- 0.5 vs. 3.9 +/- 0.5 nmol/min at 3 min of the first and second tests, p < 0.01).
CONCLUSIONS: These results indicate that the warm-up phenomenon is not attributable to increased coronary flow but to attenuation of increased regional myocardial oxygen consumption, which may be mediated by adenosine A1 receptor activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496525     DOI: 10.1016/0735-1097(93)90374-a

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

2.  Warm up phenomenon and preconditioning in clinical practice.

Authors:  F Tomai
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

Review 3.  Current Modalities and Mechanisms Underlying Cardioprotection by Ischemic Conditioning.

Authors:  John H Rosenberg; John H Werner; Michael J Moulton; Devendra K Agrawal
Journal:  J Cardiovasc Transl Res       Date:  2018-05-24       Impact factor: 4.132

4.  Relation between duration and intensity of first exercise and "warm up" in ischaemic heart disease.

Authors:  P Kay; J Kittelson; R A Stewart
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 5.  Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Authors:  G F Baxter; D M Yellon
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Is warm-up in angina ischaemic preconditioning?

Authors:  M S Marber; M D Joy; D M Yellon
Journal:  Br Heart J       Date:  1994-09

7.  Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

8.  The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon.

Authors:  Beatriz M A Ferreira; Paulo J Moffa; Andrea Falcão; Augusto Uchida; Paulo Camargo; Pascual Pereyra; Paulo R Soares; Whady Hueb; Jose A F Ramires
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-07       Impact factor: 1.468

9.  Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.

Authors:  M Kitakaze; M Hori; T Morioka; T Minamino; S Takashima; H Sato; Y Shinozaki; M Chujo; H Mori; M Inoue
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 10.  Cardiovascular effects of anti-diabetes drugs.

Authors:  Lisa M Younk; Elizabeth M Lamos; Stephen N Davis
Journal:  Expert Opin Drug Saf       Date:  2016-06-27       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.